Result of AGM

Assura

30/09/2025 15:30

RNS Number : 4645B

Assura PLC

30 September 2025

 

30 September 2025

Assura plc ("Assura" or the "Company")

Result of AGM

 

Following its annual general meeting ("AGM") held today, Assura announces the results of the poll vote for each of the resolutions submitted to the meeting (as set out in the Notice of the AGM dated 5 September 2025). All resolutions except for resolutions 13 to 16 were passed as Primary Health Properties PLC decided they were not required at the current time.

 

Resolution
For
%
For
Against
% Against
Total Votes Cast (% of issued share capital)
Votes Withheld
1. To receive the Company's annual report and accounts
3,191,210,029
99.92
2,702,703
0.08
3,193,912,732 (98.08)
24,556
2. To approve the Directors' Remuneration Policy
3,191,198,870
99.92
2,713,862
0.08
3,193,912,732 (98.08)
24,556
3. To approve the Directors' Remuneration Report
3,191,196,870
99.92
2,714,809
0.08
3,193,911,679 (98.08)
25,609
4. To re-appoint Ernst & Young LLP as auditor of the Company
3,191,210,029
99.92
2,702,703
0.08
3,193,912,732 (98.08)
24,556
5. To authorise the Audit Committee to determine the auditor's remuneration
3,191,210,029
99.92
2,702,703
0.08
3,193,912,732 (98.08)
24,556
6. To re-elect Jonathan Murphy as a Director of the Company
3,191,208,029
99.92
2,704,703
0.08
3,193,912,732 (98.08)
24,556
7. To re-elect Jayne Cottam as a Director of the Company
3,191,208,029
99.92
2,704,703
0.08
3,193,912,732 (98.08)
24,556
8. To re-elect Louise Fowler as a Director of the Company
3,190,442,909
99.89
3,469,823
0.11
3,193,912,732 (98.08)
24,556
9. To re-elect Jonathan Davies as a Director of the Company
3,189,424,843
99.86
4,487,889
0.14
3,193,912,732 (98.08)
24,556
10. To re-elect Samantha Barrell as a Director of the Company
3,190,440,909
99.89
3,471,823
0.11
3,193,912,732 (98.08)
24,556
11. To re-elect Emma Cariaga as a Director of the Company
3,191,210,029
99.92
2,702,703
0.08
3,193,912,732 (98.08)
24,556
12. To re-elect Noel Gordon as a Director of the Company
3,191,185,999
99.91
2,726,733
0.09
3,193,912,732 (98.08)
24,556
13. To authorise the Directors to allot shares
24,777,490
0.78
3,169,134,189
99.22
3,193,911,679 (98.08)
25,609
14. To authorise the Directors to disapply pre-emption rights
13,632,718
0.43
3,180,279,914
99.57
3,193,912,632 (98.08)
24,656
15. To authorise the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment
12,529,192
0.39
3,181,382,387
99.61
3,193,911,579 (98.08)
25,709
16. To authorise the market purchase of the Company's own shares
25,792,609
0.81
3,168,120,123
99.19
3,193,912,732 (98.08)
24,556
17. To authorise re-registration of the Company as a private company and adopt new articles of association
3,191,208,029
99.92
2,704,703
0.08
3,193,912,732 (98.08)
24,556
18. To authorise the Company to call any general meeting, other than an annual general meeting, by not less than 14 clear days' notice
3,190,267,614
99.89
3,645,118
0.11
3,193,912,732 (98.08)
24,556

Resolutions 1 to 12 were passed as ordinary resolutions. Resolutions 17 and 18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman.

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

3. The total number of Assura ordinary shares in issue as at 6.00 pm on 26 September 2025, the time by which shareholders who wanted to vote at the AGM must have been entered on the Company's register of members, was 3,256,393,191 and the total number of voting rights in the Company was also 3,256,393,191.

Copies of resolutions 17 and 18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

- Ends -

For more information, please contact:

Assura plc
Tel:0161 515 2043
Orla Ball, General Counsel
David Purcell, Investor Relations Director
Email:Investor@assura.co.uk
FGS Global
Gordon Simpson
 Grace Whelan
Tel:0207 251 3801
Email:Assura-LON@fgsglobal.com

 

Notes to Editors

Assura is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is currently a constituent of the EPRA* index and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portfolio was valued at £3.1 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura we BUILD for health and as a certified B Corp we are committed to keeping ESG as the heart of our strategy, creating Healthy Environments (E), Healthy Communities (S) and maintaining a Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
RAGSDEFDSEISELU